期刊文献+

黏膜愈合在炎症性肠病治疗中的作用 被引量:3

原文传递
导出
摘要 炎症性肠病(inflammatoryboweldisease,IBD)是一种病因不明确的慢性非特异性肠道炎性反应,好发于中青年,呈慢性反复性发作,以黏液血便、腹泻、腹痛、消瘦和贫血为主要表现,病程长,并发症严重,复发率高,可致中毒性巨结肠、肠穿孔、肠梗阻、肠出血、癌变,严重影响患者生活质量。IBD主要包括2种疾病类型,
作者 余乔 夏冰
出处 《中华消化杂志》 CAS CSCD 北大核心 2013年第10期718-720,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献4

二级参考文献65

  • 1[1]Scaldaferri F,Fiocchi C.Inflammatory bowel disease:progress and current concepts of etiopathogenesis.J Dig Dis 2007; 8:171-178
  • 2[2]Cosnes J,Nion-Larmurier I,Beaugerie L,Afchain P,Tiret E,Gendre JP.Impact of the increasing use of mmunosuppressants in Crohn's disease on the need for intestinal surgery.Gut 2005; 54:237-241
  • 3[3]Dubinsky MC.Azathioprine,6-mercaptopurine in inflammatory bowel disease:pharmacology,efficacy,and safety.Clin Gastroenterol Hepatol 2004; 2:731-743
  • 4[4]Siegel CA,Sands BE.Review article:practical management of inflammatory bowel disease patients taking immunomodulators.Aliment Pharmacol Ther 2005; 22:1-16
  • 5[5]Su C,Lichtenstein GR.Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.Gastroenterol Clin North Am 2004; 33:209-234,viii
  • 6[6]Sandborn W,Sutherland L,Pearson D,May G,Modigliani R,Prantera C.Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.Cochrane Database Syst Rev 2000; CD000545
  • 7[7]Pearson DC,May GR,Fick G,Sutherland LR.Azathioprine for maintaining remission of Crohn's disease.Cochrane Database Syst Rev 2000;CD000067
  • 8[8]Present DH,Meltzer SJ,Krumholz MP,Wolke A,Korelitz BI.6-Mercaptopurine in the management of inflammatory bowel disease:short-and long-term toxicity.Ann Intern Med 1989; 111:641-649
  • 9[9]Gisbert JP,Gonzelez-Lama Y,Mate J.Thiopurine-induced liver injury in patients with inflammatory bowel disease:a systematic review.Am J Gastroentero12007; 102:1518-1527
  • 10[10]Masunaga Y,Ohno K,Ogawa R,Hashiguchi M,Echizen H,Ogata H.Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.Ann Pharmacother 2007; 41:21-28

共引文献151

同被引文献26

  • 1陈灏珠.实用内科学[M].北京:人民卫生出版社,2006:1834,1918.
  • 2Contreras-Ruiz L, Schulze U, Garda-Posadas L, et al. Structural and functional alteration of corneal epithelial barrier under inflammatory conditions [J]. Curr Eye Res, 2012,37(11), 971-981. DOI, 10.3109/02713683.2012.700756.
  • 3Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system [J]. Nat Rev Drug Discov, 2014, 13(1) ..21-38. DOI.. 10. 1038/nrd4176.
  • 4Yamada S, Koyama T, Noguchi H, et al. Marine hydroquinone zonarol prevents inflammation and apoptosis in dextran sulfate sodium-induced mice ulcerative colitis[J/OL]. PLoS One, 2014, 9(11)z e113509[2014-11-19] http:// journals, plos. org/plosone/article? id ~ 10. 1371/journal. pone. 0113509. DOI.. 10. 1371/journal. pone. 0113509.
  • 5Oficjalska K, Raverdeau M, Aviello G, et al. Protective role for caspas-11 during acute experimental murine colitis[J].J Immunol, 2015,194(3)1252-1260.
  • 6Wolk K, Witte E, Witte K, et al. Biology of interleukin-22 [J]. Semin Immunopathol, 2010, 32 (1) : 17-31. DOI.. 10. 1007/s00281-009-0188-x.
  • 7Sun X, Chalmers L, Fu X, et al. A molecular link between interleukin 22 and intestinal mucosal wound healing [J]. Adv Wound Care (New Rochelle), 2012,1(6) : 231-237. 13OI= 10. 1089/wound. 2011. 0334.
  • 8Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease [J].Cytokine Growth Factor Rev, 2010,21(6) :435-441. DOI:10. 1016/j. cytogft, 2010.10.007.
  • 9Zhao J, Shi P, Sun Y, et al. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function [J].Br J Nutr, 2015, 114 ( 2 ): 181-188. DOI: 10. 1017/ S0007114515001294.
  • 10Oh SY, Cho KA, Kang JL,et al. Comparison of experimental mouse models of inflammatory bowel disease[J]. Int J Mol Med, 2014,33(2) :333-340. DOIz 10. 3892/ijmm. 2013. 1569.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部